StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Sandoz Group AG
Swiss Stock Exchange:SDZ.SW
Sector
Industries
Location
Market Cap
USD 23.79 B
Share Price
USD 55.23
Avg Daily Volume
1,125,260
Change (1 day)
1.01%
Change (1 year)
46.38%
Change (YTD)
34.38%
Sandoz Group AG Operating Cash Flow for the year ending December 31, 2024: USD 656.00 M
Sandoz Group AG Operating Cash Flow is USD 656.00 M for the year ending December 31, 2024, a 101.65% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Sandoz Group AG Operating Cash Flow for the year ending December 31, 2023 was USD 325.31 M, a -72.15% change year over year.
-
Sandoz Group AG Operating Cash Flow for the year ending December 31, 2022 was USD 1.17 B, a -5.64% change year over year.
-
Sandoz Group AG Operating Cash Flow for the year ending December 31, 2021 was USD 1.24 B, a 20.12% change year over year.
-
Sandoz Group AG Operating Cash Flow for the year ending December 31, 2020 was USD 1.03 B.
Competitors
BioMarin Pharmaceutical Inc.
USD 57.99
BMRN
+0.58
1.01%
Kyowa Kirin Co., Ltd.
USD 16.98
4151.T
-0.08
-0.44%
Bachem Holding AG
USD 72.49
BANB.SW
+1.18
1.66%
Siegfried Holding AG
USD 112.87
SFZN.SW
+1.54
1.38%
Dong-E-E-Jiao Co.,Ltd.
USD 7.16
000423.SZ
+0.01
0.21%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
USD 7.31
688336.SS
-0.01
-0.10%
Livzon Pharmaceutical Group Inc.
USD 3.76
1513.HK
-0.02
-0.48%
Xiamen Amoytop Biotech Co., Ltd.
USD 9.73
688278.SS
-0.09
-0.91%
Chengdu Kanghong Pharmaceutical Group Co., Ltd
USD 4.11
002773.SZ
-0.01
-0.22%
Jilin Aodong Pharmaceutical Group Co., Ltd.
USD 2.40
000623.SZ
+0.01
0.36%
Yifan Pharmaceutical Co., Ltd.
USD 2.00
002019.SZ
+0.08
4.31%
Beijing Aosaikang Pharmaceutical Co., Ltd.
USD 2.59
002755.SZ
+0.08
3.29%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
USD 0.70
9989.HK
-0.00
-0.52%
Concord Biotech Limited
USD 21.17
CONCORDBIO.NS
+0.25
1.22%
China Resources Boya Bio-pharmaceutical Group Co., Ltd.
USD 3.64
300294.SZ
+0.03
0.71%
Tibet Rhodiola Pharmaceutical Holding Co.
USD 5.14
600211.SS
+0.03
0.56%
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
USD 2.00
002675.SZ
-0.01
-0.47%
North China Pharmaceutical Company Ltd.
USD 0.89
600812.SS
+0.00
0.33%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
BioMarin Pharmaceutical Inc.
USD 57.99
BMRN
+0.58
1.01%
Kyowa Kirin Co., Ltd.
USD 16.98
4151.T
-0.08
-0.44%
Bachem Holding AG
USD 72.49
BANB.SW
+1.18
1.66%
Siegfried Holding AG
USD 112.87
SFZN.SW
+1.54
1.38%
Dong-E-E-Jiao Co.,Ltd.
USD 7.16
000423.SZ
+0.01
0.21%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
USD 7.31
688336.SS
-0.01
-0.10%
Livzon Pharmaceutical Group Inc.
USD 3.76
1513.HK
-0.02
-0.48%
Xiamen Amoytop Biotech Co., Ltd.
USD 9.73
688278.SS
-0.09
-0.91%
Chengdu Kanghong Pharmaceutical Group Co., Ltd
USD 4.11
002773.SZ
-0.01
-0.22%
Jilin Aodong Pharmaceutical Group Co., Ltd.
USD 2.40
000623.SZ
+0.01
0.36%
Yifan Pharmaceutical Co., Ltd.
USD 2.00
002019.SZ
+0.08
4.31%
Beijing Aosaikang Pharmaceutical Co., Ltd.
USD 2.59
002755.SZ
+0.08
3.29%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
USD 0.70
9989.HK
-0.00
-0.52%
Concord Biotech Limited
USD 21.17
CONCORDBIO.NS
+0.25
1.22%
China Resources Boya Bio-pharmaceutical Group Co., Ltd.
USD 3.64
300294.SZ
+0.03
0.71%
Tibet Rhodiola Pharmaceutical Holding Co.
USD 5.14
600211.SS
+0.03
0.56%
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
USD 2.00
002675.SZ
-0.01
-0.47%
North China Pharmaceutical Company Ltd.
USD 0.89
600812.SS
+0.00
0.33%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%